By Jeff Montgomery ( November 18, 2015, 5:32 PM EST) -- A Dyax Corp. investor on Tuesday launched a putative class action in Delaware Chancery Court challenging the biopharma company's $5.9 billion merger pact with U.K.-based drugmaker Shire PLC, saying company directors effectively undervalued Dyax and then raised barriers to alternative suitors....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.